Danielle Sloane And Morgan Tandy Outline Recent Enforcement Actions And Court Cases Involving Labs

BB
Bass, Berry & Sims

Contributor

Bass, Berry & Sims is a national law firm with nearly 350 attorneys dedicated to delivering exceptional service to numerous publicly traded companies and Fortune 500 businesses in significant litigation and investigations, complex business transactions, and international regulatory matters. For more than 100 years, our people have served as true partners to clients, working seamlessly across substantive practice disciplines, industries and geographies to deliver highly-effective legal advice and innovative, business-focused solutions. For more information, visit www.bassberry.com.
In an article for G2 Intelligence, Bass, Berry & Sims attorneys, Danielle Sloane and Morgan Tandy, outlined several recent enforcement actions and court cases involving labs.
United States Food, Drugs, Healthcare, Life Sciences

In an article for G2 Intelligence, Bass, Berry & Sims attorneys, Danielle Sloane and Morgan Tandy, outlined several recent enforcement actions and court cases involving labs. In the article, the authors examined five cases/actions and analyze their significance within the industry. Noteworthy highlights include the Department of Justice's continued investigation of potentially fraudulent kickback arrangements related to COVID-19 testing and the importance of HIPAA compliance.

The full content, "Labs in Court," was published by G2 Intelligence for its May 2024 issue (released April 25) and is available online (subscription required).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More